Relpax and Bystolic drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Relpax (eletriptan hydrobromide) and Bystolic (nebivolol hydrochloride). Common drug interactions include bronchitis among females and fungal infection among males.

The phase IV clinical study analyzes what interactions people have when they take Relpax and Bystolic. It is created by eHealthMe based on reports of 67 people who take the same drugs from the FDA, and is updated regularly.

What is Relpax?

Relpax has active ingredients of eletriptan hydrobromide. It is often used in migraine. eHealthMe is studying from 9,259 Relpax users. Check the latest studies of Relpax.

What is Bystolic?

Bystolic has active ingredients of nebivolol hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 20,662 Bystolic users. Check the latest studies of Bystolic.



On Jul, 29, 2026

67 people who take Relpax and Bystolic together, and have interactions are studied.

Relpax and Bystolic drug interactions.

What are the common drug interactions of Relpax and Bystolic, by gender? *:

female:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Headache (pain in head)
  3. Nausea (feeling of having an urge to vomit)
  4. Rash
  5. Joint injury
  6. Arthralgia (joint pain)
  7. Asthenia (weakness)
  8. Hypersomnia (excessive daytime sleepiness (eds))
  9. Lethargy (tiredness)
  10. Pruritus (severe itching of the skin)

male:

  1. Fungal infection
  2. Throat cancer
  3. Lip and/or oral cavity cancer (cancer of lip or mouth)
  4. Headache (pain in head)
  5. Pain
  6. Terminal insomnia (a sleep disorder in which there is an inability to fall asleep or to stay asleep as long as desired)

What are the common drug interactions of Relpax and Bystolic, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Dizziness
  2. Dyspnoea (difficult or laboured respiration)
  3. Pain
  4. Pulmonary embolism (blockage of the main artery of the lung)
  5. Syncope (loss of consciousness with an inability to maintain postural tone)
  6. Wheezing (a high-pitched whistling sound made while you breath)
  7. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  8. Loss of consciousness
  9. Nerve injury
  10. Road traffic accident

30-39:

n/a

40-49:

  1. Dizziness
  2. Nausea (feeling of having an urge to vomit)
  3. Activities of daily living impaired
  4. Anxiety
  5. Asthenia (weakness)
  6. Burning sensation
  7. Fibromyalgia (a long-term condition which causes pain all over the body)
  8. Injection site pain
  9. Lymphadenopathy (disease or enlargement of lymph nodes)
  10. Malaise (a feeling of general discomfort or uneasiness)

50-59:

  1. Haematocrit
  2. Haemorrhage (bleeding)
  3. Haemorrhagic cyst (bleeding cyst)
  4. Hepatic cyst
  5. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  6. Incoherent (talking in a confused and unclear way)
  7. Irritability
  8. Muscle contractions involuntary (uncontrolled muscle contraction)
  9. Nephrogenic anaemia (anaemia due to kidney disease)
  10. Fall

60+:

  1. Fungal infection
  2. Headache (pain in head)
  3. Insomnia (sleeplessness)
  4. Irritable bowel syndrome
  5. Lactose intolerance (inability to digest lactose)
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Muscular weakness (muscle weakness)
  8. Ophthalmoplegia (a paralysis or weakness of one or more of the muscles that control eye movement)
  9. Pain
  10. Sinusitis (inflammation of sinus)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 24 people, 35.82%
  2. Lichen Myxoedematosus (deposition of acid mucopolysaccharides in the skin): 8 people, 11.94%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 7 people, 10.45%
  4. Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 6 people, 8.96%
  5. Sleep Disorder: 4 people, 5.97%
  6. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 5.97%
  7. Depression: 4 people, 5.97%

* Approximation only. Some reports may have incomplete information.

Do you take Relpax and Bystolic?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Relpax and Bystolic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Relpax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bystolic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Relpax and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bystolic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on eletriptan hydrobromide and nebivolol hydrochloride (the active ingredients of Relpax and Bystolic, respectively), and Relpax and Bystolic (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: